The clinical trial investigating the validity and reliability of the L Test for gait and mobility assessment in geriatric individuals, sponsored by Hasan Kalyoncu University, is currently active but no longer recruiting participants. This study aims to provide evidence-based insights into the tool’s effectiveness in elderly populations, offering potential enhancements in patient monitoring and care.
In this article:
- What is the L Test?
- What changed?
- Clinical trial overview
- Frequently Asked Questions
- Conclusion
- Disclaimer
- Announcement
What is the L Test?
The L Test is designed to measure functional mobility in individuals, particularly focusing on gait performance. It evaluates how participants navigate short-distance walking and turning tasks, providing measurable results that support clinical decision-making. Research has indicated its promising role in assessing elderly patients with mobility challenges.
What changed?
Although previously recruiting participants, the study has entered the “active, not recruiting” phase as of December 2025. This status signals that data collection is in progress without needing additional subjects. Professionals should prepare for forthcoming updates on performance metrics and validation outcomes as the research progresses.
Clinical trial overview
Hasan Kalyoncu University oversees this investigative study on geriatric patients, primarily focusing on validating the L Test’s reliability and accuracy. The trial aims to provide empirical evidence supporting the test’s application to improve geriatric care. With elderly populations prone to mobility limitations, establishing robust tools for performance measurement is vital for medical device compliance and patient-centric outcomes.
Once findings are published, they could influence regulatory documentation and potential medical device integration within geriatric healthcare systems. Clinical teams should remain informed about these developments to assess impacts on device selection and compliance pathways.
Frequently Asked Questions
- What is the intended population for the L Test?
The test focuses on geriatric patients to assess their functional mobility. - Why is this trial significant?
It validates a tool that could refine mobility assessments and improve individualized care for elderly patients. - What should regulatory teams prepare for?
Teams should monitor upcoming trial results for impacts on medical device compliance standards.
Conclusion
The clinical trial investigating the L Test for geriatric mobility assessment progresses into an active phase without further participant enrollment. Geriatric care professionals and medical device regulatory teams should keep track of final results and analyze their implications for device application and regulatory pathways.
Disclaimer
This information is for healthcare and regulatory professionals. It does not constitute legal, clinical, or compliance advice. Validation and interpretation of findings depend on forthcoming trial results.
Announcement
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07277751?term=medical+device